Document is current
Any future updates will be listed below
-
Authors
Rouhani, Sherin J.
Hadfield, Matthew J.
Lei, Matthew
Merkin, Ross D.
Dougan, Michael
Hobbs, Gabriela S.
Hammond, Sarah P.
Reynolds, Kerry L.
- License Information
-
More Information
Article History
Received: 28 October 2025
Accepted: 8 December 2025
First Online: 7 February 2026
Declarations
:
: SJR, MJH and RM have no relevant disclosures ML has participated in advisory boards for Sanofi, Replimune, Janssen, Genmab, Eli Lilly, Genentech, as a consultant for MJH Life Sciences, Integra Connect, C4XD, and on the medical steering committee for Sanofi. MD has received consulting fees from Genentech, Gilead, Regeneron, Mallinckrodt Pharmaceuticals, Therakos, Aditum, Foghorn Therapeutics, Sorriso Pharmaceuticals, Generate Biomedicines, Asher Bio, Neoleukin Therapeutics, Alloy Therapeutics, Third Rock Ventures, DE Shaw Research, Agenus, Astellas, Alimentiv, and Curie Bio; he has research funding from Takeda; and he is a member of the Scientific Advisory Board for Monod Bio and Cerberus Therapeutics. GH has received advising/consulting fees from incyte, sobi, GSK, BMS, Cogent, Merck, Novartis, pharmaessentia SPH has research funding paid to the institution from Cidara, F2G, GSK, Mundipharma, and Scynexis and has been a consultant or advisor to Roche, Melinta, Pfizer, Takeda and Treeline Biosciences KLR: Gilead (consulting), Regeneron (consulting)
